pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
globenewswire health·Aug 7·1 min read
save

Company issues corporate announcement on senior employee transaction

Aug 7, 2026·read at globenewswire health ↗Neutral

The company released a corporate announcement identified as item 18/2026. The notice indicates that a transaction involving a leading employee has taken place.

No further details about the nature of the transaction, the employee's role, or the financial terms were provided in the announcement.

The brief filing serves to inform shareholders and the market that a senior personnel change or related deal has occurred, without elaborating on its impact.

source

This writeup was produced by pharmadog from original reporting by globenewswire health.

Original headline: “Ledende medarbejder transaktion”

read at globenewswire health ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING

related stories

  • May 4Opinion: Are blue zones real? Answering that question is harder than everSTAT
  • May 2Federal appeals court blocks mailing of abortion pill mifepristoneSTAT
  • May 1Arvinas’ ‘Protac’ breast cancer drug cleared by FDABioPharma Dive
  • Apr 30Remembering J. Craig Venter: a relentless scientist who changed biotech — and was all too easily misunderstoodSTAT
  • Apr 30Merck still sees ‘compelling’ outlook for Terns leukemia drugBioPharma Dive